Position in BLTE
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,403,079
New position
Shares Held
15,072
first reported quarter
Ownership
0.038%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 91.03635881104034.ToString("F0")%
Shared 0.ToString("F0")%
None 8.963641188959661.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Trexquant Investment LP holds $494,710,504 across 119 Biotechnology names. BLTE ranks #64 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
483,971 | $24,585,726 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
61,760 | $20,434,531 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
277,114 | $17,375,047 | |
| 4 | EXEL |
Exelixis, Inc.
|
390,818 | $16,762,184 | |
| 5 | HRMY |
Harmony Biosciences Holdings, Inc.
|
594,850 | $16,661,748 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
213,645 | $16,042,603 | |
| 7 | CNTA |
Centessa Pharmaceuticals plc
|
390,951 | $15,528,573 | |
| 8 | ASND |
Ascendis Pharma A/S
|
65,517 | $14,985,703 |
All Filings in BLTE
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,403,079 | 15,072 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||